Chemoinformaics analysis of DIHYDROXYGLUTAMIC-ACID
| Molecular Weight | 182.084 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.036 | nRig | 2 |
| Exact Molecular Weight | 182.006 | nRing | 0 |
| Solubility: LogS | -0.934 | nHRing | 0 |
| Solubility: LogP | -0.343 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 17.0968 |
| nHD | 6 | BPOL | 7.75524 |
| QED | 0.246 |
| Synth | 3.125 |
| Natural Product Likeliness | 0.493 |
| NR-PPAR-gamma | 0 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.093 |
| HIA | 0.768 |
| CACO-2 | -6.377 |
| MDCK | 0.0271714 |
| BBB | 0.814 |
| PPB | 0.162215 |
| VDSS | 0.342 |
| FU | 0.840282 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.029 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.007 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.021 |
| CL | 1 |
| T12 | 0.546 |
| hERG | 0.005 |
| Ames | 0.007 |
| ROA | 0.011 |
| SkinSen | 0.048 |
| Carcinogencity | 0.004 |
| EI | 0.965 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.860927 |